Wyeth Seeks $960 Million In Damages From Sun Pharma In Protonix Suit
This article was originally published in PharmAsia News
Executive Summary
Pfizer’s Wyeth Pharmaceuticals said it would seek $960 million in damages from India’s Sun Pharmaceuticals in a patent-infringement suit concerning Wyeth’s Protonix (pantoprazole) drug for treating ulcers.